Nicardipine
Back to searchMolecule Structure
Scientific Name
Nicardipine
Description of the Drug
Nicardipine is a calcium channel blocker used for the short-term treatment of hypertension and chronic stable angina.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00622
http://www.drugbank.ca/drugs/DB00622
Brand Name(s)
Not Available
Company Owner(s)
West-Ward Pharmaceuticals International Ltd, Hikma International Pharmaceuticals Llc, Sun Pharmaceutical Industries Ltd, Navinta Llc, Epic Pharma Inc, American Regent Inc, Eugia Pharma Specialities Ltd, Wockhardt Ltd, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Voltage-gated L-type calcium channel | PROTEIN FAMILY | BLOCKER | CHEMBL2095229 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34277 | |||
PharmGKB | PA450620 | |||
Human Metabolome Database | HMDB0014760 | |||
DrugBank | DB00622 | |||
PubChem: Thomson Pharma | 14907905 | |||
PubChem | 4474 | |||
LINCS | LSM-1418 | |||
BindingDB | 50101815 | |||
EPA CompTox Dashboard | DTXSID6023363 | |||
DrugCentral | 1909 | |||
Brenda | 69681 | 229725 | 10124 | 229726 |
ChemicalBook | CB2487861 | |||
Guide to Pharmacology | 2559 | |||
rxnorm | CARDENE | NICARDIPINE HYDROCHLORIDE | NICARDIPINE | |
KEGG Ligand | C07264 | |||
ChEBI | 180905 |